Rapid Molecular Organism Identification and Mixed Flora Antibiotic Resistance Profiling (MixAR) Prospective Study — RapIDMixAR  

Urinary Tract Infections Clinical Trial

Official title: Urinary Tract Infection: RapID Molecular Organism Identification and Mixed Flora Antibiotic Resistance Profiling (MixAR)

Status Completed

Clinical Trial Summary

In this protocol, investigators are examining the ability for a novel multiplex PCR assay with mixed floral antibiotic resistance profiling is safe and increases effective treatment for urinary tract infections in a urology clinic over traditional culture methods alone and decreases retreatment rates in this population.

Clinical Trial Description

The novel multiplex real-time PCR assay with mixed floral antibiotic resistance profiling offers a higher degree of sensitivity and specificity than conventional culture methods in the identification of UTI pathogens as determined by the previous prospective comparison study. Additionally, conventional methods are often inadequate in the case of polymicrobial infections. More accurate and timely pathogen identification allows for prompt and more targeted treatment with less reliance on empiric therapy and decreased rates of antibiotic therapy changes and retreatment. This leads to more favorable patient outcomes and decreases the development of resistant organisms. ;

Related Conditions & MeSH terms

• Cystitis
• Cystitis, Interstitial
• Infections
• Interstitial Cystitis
• Prostatitis
• Urinary Tract Infections

• NCT number: NCT03931538
• Study type: Interventional
• Source: Pathnostics
• Status: Completed
• Phase: N/A
• Start date: July 17, 2018
• Completion date: October 1, 2019